GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Artificial Intelligence /LLMs Rapidly Transform European Gastroenterology Practice : Gut | June 2026
14

LLMs Rapidly Transform European Gastroenterology Practice : Gut | June 2026

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated June 1, 2026

Introduction:

Large language models (LLMs), exemplified by ChatGPT and similar artificial intelligence platforms, are rapidly reshaping healthcare delivery, medical education, and scientific research. In gastroenterology, these technologies have the potential to support clinical decision-making, streamline documentation, enhance endoscopy workflows, and improve academic productivity. Despite their growing visibility, real-world data on how gastroenterologists are using LLMs in daily practice have been limited.

Problem Statement:

The widespread adoption of LLMs has occurred faster than the development of formal training programs, governance frameworks, and specialty-specific guidance. Understanding current patterns of use, perceived benefits, concerns, and barriers is essential for ensuring safe and effective integration of these technologies into gastroenterology practice.

Summary:

The EuroGI-AI project provides the largest assessment to date of LLM adoption among European gastroenterologists. The survey demonstrated that more than half of respondents already use LLMs in their clinical or academic activities, with many engaging with these tools on a weekly or daily basis. Educational purposes, clinical decision support, and scientific writing emerged as the most common applications. Among academic users, literature summarization and language refinement were particularly valued, highlighting the growing role of AI in research productivity. Most respondents considered LLMs reliable and believed they improve professional efficiency and clinical outcomes. Notably, many clinicians also recognized potential applications within endoscopy practice. However, concerns regarding inaccuracies remained common and were associated with reduced trust in AI-generated outputs. Despite widespread use, formal training was uncommon, yet there was overwhelming support for structured educational programs and incorporation of AI competencies into gastroenterology curricula. Institutional restrictions, financial costs, technological complexity, and time limitations were identified as key barriers to broader adoption. Overall, the findings suggest that LLMs are rapidly becoming integrated into European gastroenterology practice. Future success will depend on specialty-specific development, structured training, robust governance frameworks, and ongoing evaluation to ensure safe, ethical, and clinically meaningful implementation of AI technologies.

Related Q&A

15

Competing Risk Analysis in HCT & IEC Research : Transplant Cell Ther | May 2026

Introduction Competing risks are frequently encountered in hematopoietic cell transplantation (HCT) and immune effector cell (IEC) therapy research, particularly when mutually exclusive outcomes coexist. A classical example is...

16

AI Meets Endoscopy for early ESCC Detection: Endoscopy | April 2026

Introduction Esophageal squamous cell carcinoma is a highly aggressive malignancy where early detection and accurate assessment of invasion depth are critical for determining optimal treatment strategies. Current tools...

17

AI-Based Risk Prediction for HCC: Cancer Discovery | April 2026

Hepatocellular carcinoma (HCC) remains one of the most lethal cancers globally, largely due to late diagnosis and inadequate risk stratification. Current clinical risk scores have limited predictive accuracy...

18

AI for Endoscopic and Histologic Assessment in IBD Trials: J Crohn’s and Colitis, March 2026

Introduction Accurate assessment of disease activity in inflammatory bowel disease (IBD) clinical trials relies on central reading of endoscopic and histologic images. Although considered the current gold standard,...

19

AI-Enabled Imaging for Predicting Postoperative Recurrence in Crohn’s Disease: Gut, March 2026

Postoperative recurrence (POR) remains a major challenge in Crohn’s disease (CD), occurring in up to 70% of patients within the first year after intestinal resection. Current surveillance strategies—primarily...

20

ACG Delphi Consensus on AI in GI- AMJ Feb.26

This American College of Gastroenterology (ACG)–led modified Delphi consensus provides a comprehensive framework for responsible integration of artificial intelligence (AI) into gastroenterology, hepatology, and endoscopy practice. A multidisciplinary...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer